Literature DB >> 17784837

Phenotypic and functional comparison of mesenchymal stem cells derived from the bone marrow of normal adults and patients with hematologic malignant diseases.

Zhi-Gang Zhao1, Yan Liang, Kai Li, Wei-Ming Li, Qiu-Bai Li, Zhi-Chao Chen, Ping Zou.   

Abstract

Mesenchymal stem cells (MSCs) have received much attention for their ability to differentiate into various cell types under specific conditions and to support the proliferation of hematopoietic stem cells. However, it is unclear whether the characteristics of MSCs are altered in different disease states. In this study, we obtained and expanded MSCs from bone marrow of patients with acute lymphoblastic leukemia (ALL), Hodgkin disease (HD), and non-Hodgkin lymphoma (NHL). Our results showed that MSCs derived from ALL, HD, and NHL were similar to normal adult bone marrow-derived MSCs in morphology, growth properties, surface epitopes, and differentiation ability in vitro. Moreover, MSCs derived from ALL, NHL, and HD had a normal karyotype and ultrastructure. These cells could express hematopoietic cytokines and support hematopoiesis in long-term culture. However, adherent cells isolated from bone marrow of patients with acute myeloid leukemia (AML) showed abnormal biological properties, including heterogeneity in morphology, limited proliferation capacity, and impaired differentiation and hematopoiesis support ability. These results indicate that there are differences in the characteristics of adherent cells derived from different disease states, which may be important for reasonable MSC selection in stem cell-based therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17784837     DOI: 10.1089/scd.2007.0008

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  22 in total

Review 1.  Role of mesenchymal stem cells in leukaemia: Dr. Jekyll or Mr. Hyde?

Authors:  Rebecca S Y Wong; Soon-Keng Cheong
Journal:  Clin Exp Med       Date:  2013-06-23       Impact factor: 3.984

2.  Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production.

Authors:  Karen McLean; Yusong Gong; Yunjung Choi; Ning Deng; Kun Yang; Shoumei Bai; Lourdes Cabrera; Evan Keller; Laurie McCauley; Kathleen R Cho; Ronald J Buckanovich
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

Review 3.  Use of mesenchymal stem cells for therapy of cardiac disease.

Authors:  Vasileios Karantalis; Joshua M Hare
Journal:  Circ Res       Date:  2015-04-10       Impact factor: 17.367

4.  NFĸB Targeting in Bone Marrow Mesenchymal Stem Cell-Mediated Support of Age-Linked Hematological Malignancies.

Authors:  Lauren S Sherman; Shyam A Patel; Marianne D Castillo; Rachel Unkovic; Marcelo Taborga; Marina Gergues; Shaun Patterson; Jean-Pierre Etchegaray; Mohammed Jaloudi; Anupama Hooda-Nehra; Joshua Kra; Darling P Rojas; Victor T Chang; Pranela Rameshwar
Journal:  Stem Cell Rev Rep       Date:  2021-08-19       Impact factor: 5.739

Review 5.  Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.

Authors:  M Mimeault; S K Batra
Journal:  Panminerva Med       Date:  2008-03       Impact factor: 5.197

6.  Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.

Authors:  Yevgeniya Le; Sylvain Fraineau; Priya Chandran; Mitchell Sabloff; Marjorie Brand; Jessie R Lavoie; Rémi Gagne; Michael Rosu-Myles; Carole L Yauk; Richard B Richardson; David S Allan
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

7.  Mesenchymal stem cells derived from bone marrow of diabetic patients portrait unique markers influenced by the diabetic microenvironment.

Authors:  Smruti M Phadnis; Surendra M Ghaskadbi; Anandwardhan A Hardikar; Ramesh R Bhonde
Journal:  Rev Diabet Stud       Date:  2009-12-30

8.  Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia.

Authors:  S Geyh; M Rodríguez-Paredes; P Jäger; C Khandanpour; R-P Cadeddu; J Gutekunst; C M Wilk; R Fenk; C Zilkens; D Hermsen; U Germing; G Kobbe; F Lyko; R Haas; T Schroeder
Journal:  Leukemia       Date:  2015-11-25       Impact factor: 11.528

9.  Promise(s) of mesenchymal stem cells as an in vitro model system to depict pre-diabetic/diabetic milieu in WNIN/GR-Ob mutant rats.

Authors:  Soundarya L Madhira; Satya S Challa; Maniprabha Chalasani; Giridharan Nappanveethl; Ramesh R Bhonde; Rajanna Ajumeera; Vijayalakshmi Venkatesan
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

Review 10.  Stem cells and bone diseases: new tools, new perspective.

Authors:  Mara Riminucci; Cristina Remoli; Pamela G Robey; Paolo Bianco
Journal:  Bone       Date:  2014-09-18       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.